JANX Market Cap & Key Metrics
Janux Therapeutics, Inc.
$12.27
+$0.23(+1.87%)
53
Overall
60
Value
50
Tech
50
Quality
Market Cap
$750.41M
Volume
724.49K
52W Range
$12.12 - $35.34
Target Price
$31.31
JANX market cap is $750.41M. This page lists Janux Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
JANX Key Metrics
- Market cap
- $750.41M
- EPS estimate, current year
- $-1.70
- EPS growth, 3-year
- -6.38%
- Value score
- 60
- Quality score
- 50
- Technical score
- 50
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $10.00M | $10.59M | $8.08M | $8.61M | $3.64M |
| EBITDA | -$155.64M | -$66.93M | -$56.34M | -$65.97M | -$32.73M |
| EPS | $-1.83 | $-1.28 | $-1.32 | $-1.52 | $-1.39 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | JANX | $12.27 | +1.9% | 724.49K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Janux Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW